PG · Procter & Gamble Co - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.23B | $22.21B | $22.39B | $21.88B | $19.78B | $21.74B | $21.44B | $20.20B | $21.87B | $20.77B |
| Cost of Revenue | $10.72B | $10.83B | $10.89B | $10.42B | $9.69B | $10.42B | $10.14B | $9.86B | $10.50B | $10.90B |
| Gross Profit | $10.51B | $11.37B | $11.50B | $11.46B | $10.08B | $11.32B | $11.30B | $10.34B | $11.37B | $9.88B |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $5.94B | $6.01B | $5.64B | $5.72B | $5.52B | $5.52B | $5.52B | $5.88B | $5.60B | $5.09B |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $690.00M | $706.00M | $761.00M | - | - | $702.00M | - | - | $702.00M | - |
| Operating Income | $4.58B | $5.37B | $5.86B | $5.74B | $4.56B | $5.80B | $4.43B | $4.46B | $5.77B | $4.79B |
| Interest Expense | $223.00M | $220.00M | $197.00M | $248.00M | $233.00M | $238.00M | $248.00M | $233.00M | $225.00M | $171.00M |
| Income Tax | $1.04B | $1.09B | $1.25B | $1.19B | $868.00M | $1.15B | $1.00B | $812.00M | $1.25B | $876.00M |
| Net Income | $3.93B | $4.32B | $4.75B | $4.63B | $3.77B | $3.96B | $3.47B | $3.75B | $4.52B | $3.93B |
| EPS - Basic | $1.66 | $1.82 | $2.00 | $1.94 | $1.58 | $1.65 | $1.44 | $1.56 | $1.89 | $1.63 |
| EPS - Diluted | $1.63 | $1.78 | $1.95 | $1.88 | $1.54 | $1.61 | $1.40 | $1.52 | $1.83 | $1.59 |
Balance Sheet
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12.31B | $10.82B | $11.17B | $9.56B | $9.12B | $12.16B | $9.48B | $6.83B | $9.73B | $8.25B |
| Accounts Receivable | $6.32B | $6.28B | $6.49B | $6.18B | $6.14B | $6.31B | $6.12B | $6.12B | $6.21B | $5.47B |
| Inventory | $7.85B | $7.82B | $7.85B | $7.55B | $7.40B | $7.29B | $7.02B | $7.08B | $7.12B | $7.07B |
| Accounts Payable | $15.03B | $15.17B | $15.61B | $15.23B | $14.51B | $15.35B | $15.36B | $13.69B | $14.44B | $14.60B |
| Current Assets | $27.99B | $26.59B | $27.12B | $25.39B | $24.43B | $27.45B | $24.71B | $22.46B | $24.94B | $22.65B |
| Total Assets | $128.38B | $127.29B | $127.60B | $125.23B | $122.98B | $126.48B | $122.37B | $119.60B | $122.53B | $120.83B |
| Current Liabilities | $38.23B | $36.70B | $37.99B | $36.06B | $34.25B | $36.42B | $33.63B | $32.34B | $37.16B | $35.76B |
| Long-term Debt | $23.85B | $25.58B | $24.32B | $25.00B | $24.25B | $25.74B | $25.27B | $24.25B | $24.07B | $24.38B |
| Total Liabilities | $73.65B | $73.97B | $74.05B | $72.95B | $70.44B | $74.34B | $71.81B | $69.26B | $74.52B | $73.76B |
| Stockholders' Equity | $54.73B | $53.32B | $53.55B | $52.28B | $52.55B | $52.14B | $50.56B | $50.33B | $48.01B | $47.06B |
| Retained Earnings | $135.42B | $133.98B | $132.21B | $129.97B | $128.92B | $125.36B | $123.81B | $123.13B | $120.44B | $118.17B |
Cash Flow
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $5.41B | - | - | $4.30B | - | - | $4.90B | - |
| Investing Cash Flow | - | - | ($1.53B) | - | - | ($1.11B) | - | - | ($1.22B) | - |
| Financing Cash Flow | - | - | ($2.24B) | - | - | ($634.00M) | - | - | ($2.04B) | - |
| CapEx | - | - | $1.20B | - | - | $993.00M | - | - | $925.00M | - |
| Free Cash Flow | - | - | $4.21B | - | - | $3.31B | - | - | $3.98B | - |
Ratios
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 49.5% | 51.2% | 51.4% | 52.4% | 51.0% | 52.1% | 52.7% | 51.2% | 52.0% | 47.5% |
| Operating margin | 21.5% | 24.2% | 26.2% | 26.2% | 23.0% | 26.7% | 20.7% | 22.1% | 26.4% | 23.0% |
| EBITDA margin | 24.8% | 27.3% | 29.6% | - | - | 29.9% | - | - | 29.6% | - |
| Net margin | 18.5% | 19.4% | 21.2% | 21.2% | 19.1% | 18.2% | 16.2% | 18.6% | 20.7% | 18.9% |
| Free cash flow margin | - | - | 18.8% | - | - | 15.2% | - | - | 18.2% | - |
| FCF / Net income | - | - | 0.89 | - | - | 0.84 | - | - | 0.88 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 28.0% | 27.1% | 25.2% | 26.2% | 27.9% | 25.4% | 25.8% | 29.1% | 25.6% | 24.5% |
| Effective tax rate | 20.9% | 20.2% | 20.9% | 20.4% | 18.7% | 22.5% | 22.4% | 17.8% | 21.6% | 18.2% |
| Return on assets | 3.1% | 3.4% | 3.7% | 3.7% | 3.1% | 3.1% | 2.8% | 3.1% | 3.7% | 3.3% |
| Return on equity | 7.2% | 8.1% | 8.9% | 8.9% | 7.2% | 7.6% | 6.9% | 7.5% | 9.4% | 8.4% |
| Return on invested capital | 4.6% | 5.4% | 6.0% | 5.9% | 4.8% | 5.8% | 4.5% | 4.9% | 6.3% | 5.5% |
| Liquidity | ||||||||||
| Current ratio | 0.73 | 0.72 | 0.71 | 0.70 | 0.71 | 0.75 | 0.73 | 0.69 | 0.67 | 0.63 |
| Quick ratio | 0.53 | 0.51 | 0.51 | 0.49 | 0.50 | 0.55 | 0.53 | 0.48 | 0.48 | 0.44 |
| Cash ratio | 0.32 | 0.29 | 0.29 | 0.27 | 0.27 | 0.33 | 0.28 | 0.21 | 0.26 | 0.23 |
| Leverage | ||||||||||
| Debt / Equity | 0.44 | 0.48 | 0.45 | 0.48 | 0.46 | 0.49 | 0.50 | 0.48 | 0.50 | 0.52 |
| Debt / Assets | 0.19 | 0.20 | 0.19 | 0.20 | 0.20 | 0.20 | 0.21 | 0.20 | 0.20 | 0.20 |
| Debt / EBITDA | 4.53 | 4.21 | 3.67 | - | - | 3.96 | - | - | 3.72 | - |
| Interest coverage | 20.5x | 24.4x | 29.7x | 23.1x | 19.6x | 24.4x | 17.9x | 19.1x | 25.6x | 28.0x |
| Equity multiplier | 2.35 | 2.39 | 2.38 | 2.40 | 2.34 | 2.43 | 2.42 | 2.38 | 2.55 | 2.57 |
| Liabilities / Assets | 0.57 | 0.58 | 0.58 | 0.58 | 0.57 | 0.59 | 0.59 | 0.58 | 0.61 | 0.61 |
| Efficiency | ||||||||||
| Asset turnover | 0.17 | 0.17 | 0.18 | 0.17 | 0.16 | 0.17 | 0.18 | 0.17 | 0.18 | 0.17 |
| Inventory turnover | 1.37 | 1.39 | 1.39 | 1.38 | 1.31 | 1.43 | 1.45 | 1.39 | 1.48 | 1.54 |
| Days sales outstanding | 109d | 103d | 106d | 103d | 113d | 106d | 104d | 111d | 104d | 96d |
| Days inventory outstanding | 267d | 263d | 263d | 265d | 279d | 255d | 252d | 262d | 247d | 237d |
| Days payable outstanding | 512d | 511d | 523d | 533d | 546d | 538d | 553d | 507d | 502d | 489d |
| Cash conversion cycle | -136d | -145d | -154d | -166d | -154d | -176d | -196d | -134d | -151d | -156d |
| Valuation | ||||||||||
| P / E | 88.6x | 80.5x | 78.8x | 84.7x | 110.7x | 107.6x | 117.8x | 106.7x | 79.7x | 95.4x |
| P / B | 6.4x | 6.5x | 7.0x | 7.5x | 7.9x | 8.2x | 8.1x | 8.0x | 7.5x | 8.0x |
| P / S | 16.4x | 15.6x | 16.7x | 17.9x | 21.1x | 19.6x | 19.0x | 19.9x | 16.5x | 18.1x |
| EV / EBITDA | 68.5x | 59.6x | 58.6x | - | - | 67.8x | - | - | 58.0x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 7.4% | 1.5% | 3.0% | 2.1% | -2.1% | -0.6% | 3.2% | 0.6% | 6.1% | -0.9% |
| Revenue CAGR (3y) | 1.9% | 2.3% | 2.8% | 1.5% | 0.7% | 2.2% | 2.8% | 3.7% | 4.2% | 4.4% |
| Revenue CAGR (5y) | 3.2% | 2.4% | 3.0% | 3.7% | 2.8% | 4.1% | 4.3% | 4.2% | 5.6% | 3.6% |
| Gross profit growth (YoY) | 4.3% | -0.8% | 1.6% | 1.5% | -2.5% | -0.5% | 14.4% | 7.0% | 16.4% | -4.0% |
| Operating income growth (YoY) | 0.4% | -6.5% | 1.0% | 29.5% | 2.2% | 0.5% | -7.4% | 5.0% | 16.8% | -7.4% |
| Net income growth (YoY) | 4.3% | -6.7% | 20.0% | 33.5% | 0.4% | -12.4% | -11.8% | 10.5% | 14.8% | -6.9% |
| EPS growth (YoY) | 5.8% | -5.3% | 21.1% | 34.3% | 1.3% | -12.0% | -11.9% | 10.9% | 16.6% | -4.2% |
| EPS CAGR (3y) | 6.0% | 3.8% | 7.5% | 4.2% | 5.0% | 0.0% | -1.6% | 6.5% | 3.9% | 4.1% |
| EPS CAGR (5y) | 5.3% | 3.9% | 3.7% | 5.9% | 6.6% | 3.4% | 2.8% | 7.9% | 8.4% | 11.3% |
| FCF growth (YoY) | - | - | 27.2% | - | - | -16.8% | - | - | 25.1% | - |
| FCF CAGR (5y) | - | - | 1.6% | - | - | 1.4% | - | - | 9.9% | - |
| Book value growth (YoY) | 4.2% | 2.0% | 2.7% | 3.4% | 4.4% | 8.6% | 7.4% | 10.8% | 8.3% | 0.5% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-06-30.
Business segments
$83.49B totalFabric Home Care Segment$29.62B · 35.5%
Baby Feminine Family Care Segment$20.25B · 24.3%
Beauty Segment$14.96B · 17.9%
Health Care Segment$12.00B · 14.4%
Grooming Segment$6.66B · 8.0%
Geographic
$84.30B totalNon Us$42.70B · 50.7%
US$41.60B · 49.3%
Peer comparison
Same SIC group: Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Comparing PROCTER & GAMBLE Co against the 5 most active filers in the same SIC group.
Dividends
$4.26/share trailing 12 months · +4.5% YoY
| Ex-date | Per share |
|---|---|
| Apr 24, 2026 | $1.0890 |
| Jan 23, 2026 | $1.0570 |
| Oct 24, 2025 | $1.0570 |
| Jul 18, 2025 | $1.0570 |
| Apr 21, 2025 | $1.0570 |
| Jan 24, 2025 | $1.0070 |
| Oct 18, 2024 | $1.0070 |
| Jul 19, 2024 | $1.0070 |
| Apr 18, 2024 | $1.0070 |
| Jan 18, 2024 | $0.9410 |
| Oct 19, 2023 | $0.9410 |
| Jul 20, 2023 | $0.9410 |
| Apr 20, 2023 | $0.9410 |
| Jan 19, 2023 | $0.9130 |
| Oct 20, 2022 | $0.9130 |
| Jul 21, 2022 | $0.9130 |
| Apr 21, 2022 | $0.9130 |
| Jan 20, 2022 | $0.8700 |
| Oct 21, 2021 | $0.8700 |
| Jul 22, 2021 | $0.8700 |
| Apr 22, 2021 | $0.8700 |
| Jan 21, 2021 | $0.7910 |
| Oct 22, 2020 | $0.7910 |
| Jul 23, 2020 | $0.7910 |